Disease
Kaposi’s Sarcoma

Overview of Kaposi’s Sarcoma

Kaposi’s Sarcoma is a rare type of cancer that develops from the cells lining lymph or blood vessels. It is most commonly associated with immunocompromised individuals, especially those living with HIV/AIDS. It appears as tumors on the skin, inside the mouth, or other organs. The disease is caused by infection with the Kaposi’s Sarcoma-associated Herpesvirus (KSHV), also known as Human Herpesvirus 8 (HHV-8). While not everyone infected with the virus develops cancer, those with weakened immune systems are at higher risk.

Types of Kaposi’s Sarcoma

  • Epidemic (AIDS-related) Kaposi’s Sarcoma: Seen in people living with HIV/AIDS; the most common form globally.
  •  Classic Kaposi’s Sarcoma: A slow-growing form, typically affecting elderly men of Mediterranean or Eastern European descent.
  •  Endemic (African) Kaposi’s Sarcoma: Found in some African regions, especially in children or adults without HIV.
  •  Iatrogenic (Transplant-related) Kaposi’s Sarcoma: Occurs in patients who are immunosuppressed after organ transplantation.
  •  Non-epidemic Kaposi’s Sarcoma: Rare and occurs in people without obvious immune deficiency.

Symptoms of Kaposi’s Sarcoma

  • Purplish, reddish, or brown skin lesions or nodules
  • Swelling in legs or face due to lymphatic blockage
  • Lesions inside the mouth or throat
  • Respiratory symptoms if lungs are involved
  • Gastrointestinal bleeding or discomfort when internal organs are affected
  • Lesions may be painless or painful depending on location

Causes of Kaposi’s Sarcoma

  • Infection with Kaposi’s Sarcoma-associated Herpesvirus (KSHV/HHV-8)
  • Immune suppression (especially in HIV/AIDS or post-transplant patients)
  • Genetic predisposition in certain ethnic groups
  • High viral load of KSHV in some individuals

Complications in Kaposi’s Sarcoma

  • Severe pain or bleeding from internal lesions
  • Opportunistic infections due to immune suppression
  • Organ damage (lungs, liver, digestive tract)
  • Psychological distress or stigma from visible lesions
  • Risk of secondary infections and treatment side effects

Risk Factors of Kaposi’s Sarcoma

  • Being HIV-positive, especially with low CD4 count
  • Organ transplant recipients on long-term immunosuppressants
  • Men of Mediterranean, Middle Eastern or African descent
  • Sexual contact with someone infected with KSHV
  • Living in or traveling to endemic areas

Preventions of Kaposi’s Sarcoma

  • Early and effective antiretroviral therapy (ART) in HIV-positive individuals
  • Safe sex practices to reduce transmission of KSHV
  • Screening and monitoring in transplant patients
  • Avoidance of unnecessary immunosuppressants
  • Community education about transmission and symptoms

Diagnosis of Kaposi’s Sarcoma

  • Physical examination of skin and oral lesions
  • Biopsy and histopathological analysis of lesions
  • PCR test to detect KSHV DNA
  • Imaging tests (CT scan, endoscopy) for internal involvement
  • Blood tests to assess immune status (CD4 count in HIV)

Treatments of Kaposi’s Sarcoma

  • Antiretroviral therapy (ART) for HIV-positive patients
  • Chemotherapy for widespread or aggressive disease
  • Radiation therapy for localized lesions
  • Topical treatments for skin lesions
  • Immunotherapy in select cases
  • Management of pain, swelling and secondary infections

Prognosis of Kaposi’s Sarcoma

  • Good prognosis when caught early and managed with ART
  • Long-term remission possible with proper treatment
  • Prognosis varies with immune status and extent of spread
  • Monitoring is essential to prevent recurrence or complications

Care at MyhealthMydoctor

  • Expert oncologists and infectious disease specialists
  • Personalised treatment plans combining cancer care with immune support
  • Assistance with diagnosis, biopsy and staging
  • Ongoing support for HIV/AIDS management if applicable
  • Compassionate care that focuses on emotional and physical well-being

Some Important Questions Patients Should Ask Their Doctor During a Consultation

  • What type of Kaposi’s Sarcoma do I have?
  •  Is it linked to HIV or another condition in my case?
  •  What are my treatment options and success rates?
  •  Will the lesions go away completely with treatment?
  •  Can Kaposi’s Sarcoma come back after treatment?
  •  How will you monitor my response to therapy?
  •  Should my family members be tested for KSHV?

What Patients Expect from Doctors During Consultation?

  • Clear explanation of disease type and stage
  • Guidance on treatment timelines and outcomes
  • Honest discussion about HIV or immune-related risks
  • Emotional reassurance and psychological support
  • Continued follow-up and monitoring plans
  • Integration with HIV care or transplant follow-up, if needed